Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids

14 Oct 2015

Abstract excerpt

// Huabo Wang 1 , Peter Teriete 2 , Angela Hu 1 , Dhanya Raveendra-Panickar 2 , Kelsey Pendelton 1 , John S. Lazo 3 , Julie Eiseman 4,5 , Toril Holien 6 , Kristine Misund 6 , Ganna Oliynyk 7 , Marie Arsenian-Henriksson 7 , Nicholas D. P. Cosford 2 , Anders Sundan 6 and Edward V. Prochownik 1,5,8 1 Section of Hematology/Oncology, Children’s Hospital of Pittsburgh of UPMC, The University of Pittsburgh Medical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Multiple Myeloma Research and Treatments
Share to Protein Degradation and Inhibitors
Share to Ubiquitin and proteasome pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26474287
DOI: 10.18632/oncotarget.6116

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoidsPMID 26474287Read ↗

Structurally diverse c-Myc inhibitors share a common mechanism of action involving ATP depletionSemantic proximity Read ↗

A novel inhibitor L755507 efficiently blocks c-Myc–MAX heterodimerization and induces apoptosis in cancer cellsSemantic proximity Read ↗

A selective high affinity MYC-binding compound inhibits MYC:MAX interaction and MYC-dependent tumor cell proliferationSemantic proximity Read ↗

Targeting of the MYCN Protein with Small Molecule c-MYC InhibitorsSemantic proximity Read ↗

Small-molecule inhibitors of c-Myc transcriptional factor suppress proliferation and induce apoptosis of promyelocytic leukemia cell via cell cycle arrestSemantic proximity Read ↗

Celastrol induces DNA damage and cell death in BCR-ABL T315I-mutant CML by targeting YY1 and HMCES.Semantic proximity Read ↗

Strategies to target the cancer driver MYC in tumor cellsSemantic proximity Read ↗

Synthetic and Naturally Occurring Heterocyclic Anticancer Compounds with Multiple Biological TargetsSemantic proximity Read ↗

Alternative approaches to target Myc for cancer treatmentSemantic proximity Read ↗

Inhibition of mTOR-kinase destabilizes MYCN and is a potential therapy for MYCN-dependent tumorsSemantic proximity Read ↗

In vivo quantification and perturbation of Myc-Max interactions and the impact on oncogenic potentialSemantic proximity Read ↗

MYC modulators in cancer: a patent reviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.